Abbott Laboratories
DE ˙ XTRA ˙ US0028241000
75,22 € ↑1,20 (1,62%)
2026-06-03
AKTIENPREIS
SecurityDE:ABL / Abbott Laboratories
InstitutionVance Wealth, Inc.
Latest Disclosed Ownership3,636 shares
Latest Disclosed Value $ 373,311
Vance Wealth, Inc. reports 0.39% increase in ownership of ABL / Abbott Laboratories

On May 15, 2026 - Vance Wealth, Inc. filed a 13F-HR form disclosing ownership of 3,636 shares of Abbott Laboratories (DE:ABL) valued at $322,950 USD as of March 31, 2026. The entity filed a previous 13F-HR/A on February 17, 2026 disclosing 3,622 shares of Abbott Laboratories. This represents a change in shares of 0.39% during the quarter. The current value of the position is $273,500 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F ABBOTT LABORATORIES COM 002824100 3,636 14 0.39 373 -17.66 0.1078
2026-02-17 2025-12-31 13F/A-1 ABBOTT LABS COM 002824100 3,622 12 0.33 454 -6.21 0.1348
2026-02-17 2025-12-31 13F ABBOTT LABS COM 002824100 3,622 12 454 0.1348
2025-11-14 2025-09-30 13F ABBOTT LABS COM 002824100 3,610 66 1.86 484 0.21 0.1487
2025-08-13 2025-06-30 13F ABBOTT LABS COM 002824100 3,544 20 0.57 482 3.21 0.1626
2025-05-14 2025-03-31 13F ABBOTT LABS COM 002824100 3,524 -104 -2.87 467 13.90 0.1757
2025-02-14 2024-12-31 13F ABBOTT LABS COM 002824100 3,628 44 1.23 410 0.49 0.1585
2024-11-08 2024-09-30 13F ABBOTT LABS COM 002824100 3,584 -222 -5.83 409 3.29 0.1547
2024-08-02 2024-06-30 13F ABBOTT LABS COM 002824100 3,806 7 0.18 395 -8.35 0.1624
2024-04-30 2024-03-31 13F ABBOTT LABS COM 002824100 3,799 59 1.58 432 4.87 0.1720
2024-02-05 2023-12-31 13F ABBOTT LABS COM 002824100 3,740 -569 -13.20 412 -1.44 0.1786
2023-11-03 2023-09-30 13F ABBOTT LABS COM 002824100 4,309 -167 -3.73 417 -14.37 0.1953
2023-08-02 2023-06-30 13F ABBOTT LABS COM 002824100 4,476 291 6.95 488 15.13 0.2222
2023-05-10 2023-03-31 13F ABBOTT LABS COM 002824100 4,185 0 0.00 424 -7.84 0.2277
2023-01-27 2022-12-31 13F ABBOTT LABS COM 002824100 4,185 0 0.00 459 13.33 0.2866
2022-10-31 2022-09-30 13F ABBOTT LABS COM 002824100 4,185 -10 -0.24 405 -11.18 0.3113
2022-08-09 2022-06-30 13F ABBOTT LABS COM 002824100 4,195 10 0.24 456 -7.88 0.3526
2022-05-13 2022-03-31 13F ABBOTT LABS COM 002824100 4,185 0 0.00 495 -15.96 0.6263
2022-02-18 2021-12-31 13F ABBOTT LABS COM 002824100 4,185 4,185 589 0.5779
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.